Blueprint Medicines Change in Accounts Payable 2014-2025 | BPMC
Blueprint Medicines change in accounts payable for the twelve months ending March 31, 2025 was $-0.004B, a 156.4% decline year-over-year.
- Blueprint Medicines annual change in accounts payable for 2024 was $0.002B, a 16.86% increase from 2023.
- Blueprint Medicines annual change in accounts payable for 2023 was $0.002B, a 132.32% decline from 2022.
- Blueprint Medicines annual change in accounts payable for 2022 was $-0.006B, a 237.79% decline from 2021.